REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 67 filers reported holding REDHILL BIOPHARMA LTD in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2 | -100.0% | 14,587 | +34.6% | 0.00% | – |
Q3 2022 | $5,000 | -50.0% | 10,837 | -9.2% | 0.00% | – |
Q2 2022 | $10,000 | -66.7% | 11,937 | -2.5% | 0.00% | – |
Q1 2022 | $30,000 | +7.1% | 12,237 | +8.9% | 0.00% | – |
Q4 2021 | $28,000 | -47.2% | 11,237 | -3.9% | 0.00% | – |
Q3 2021 | $53,000 | -57.6% | 11,687 | -24.8% | 0.00% | – |
Q4 2020 | $125,000 | +16.8% | 15,550 | +47.4% | 0.00% | – |
Q3 2020 | $107,000 | +109.8% | 10,550 | -6.8% | 0.00% | – |
Q1 2020 | $51,000 | -21.5% | 11,325 | +13.0% | 0.00% | – |
Q2 2019 | $65,000 | -21.7% | 10,025 | 0.0% | 0.00% | – |
Q1 2019 | $83,000 | +25.8% | 10,025 | -16.6% | 0.00% | – |
Q4 2018 | $66,000 | – | 12,025 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ibex Investors LLC | 715,293 | $3,276,000 | 0.69% |
GAGNON SECURITIES LLC | 392,245 | $1,796,000 | 0.27% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,976,476 | $9,052,000 | 0.18% |
Annandale Capital, LLC | 43,532 | $199,000 | 0.12% |
Henry James International Management Inc. | 75,078 | $344,000 | 0.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 38,581 | $177,000 | 0.09% |
Claret Asset Management Corp | 62,730 | $287,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 104,754 | $480,000 | 0.05% |
WOODWARD DIVERSIFIED CAPITAL, LLC | 17,089 | $78,000 | 0.05% |
ARS Investment Partners, LLC | 52,495 | $240,000 | 0.02% |